Moderate to Severe Plaque Psoriasis
Also known as: Moderate-to-severe Plaque Psoriasis
Drug | Drug Name | Drug Description |
---|---|---|
DB08904 | Certolizumab pegol | A tumor necrosis factor (TNF) blocker used to treat a variety of autoimmune and autoinflammatory conditions like Crohn's disease, rheumatoid arthritis, active psoriatic arthritis, ankylosing spondylitis, axial spondyloarthritis, and plaque psoriasis. |
DB11569 | Ixekizumab | A monoclonal antibody used to treat moderate to severe plaque psoriasis. |
DB00563 | Methotrexate | An antineoplastic agent used the treatment of a wide variety of cancers as well as severe psoriasis, severe rheumatoid arthritis, and juvenile rheumatoid arthritis. |
DB14512 | Mometasone furoate | A corticosteroid used to treat asthma, allergic rhinitis, nasal congestion, nasal polyps, dermatitis, and pruritus. |
DB14004 | Tildrakizumab | An interleukin-23 antagonist used to treat moderate to severe plaque psoriasis. |